Oxaliplatin 50mg/100mg Injection – Trusted Oncology Medicine Exporter from India
Looking for a reliable Oxaliplatin 50mg/100mg Injection exporter with assured quality and fast international delivery?
Cordium Pharmaceuticals Pvt. Ltd. is a trusted pharmaceutical exporter from India specializing in supplying high-quality oncology medicines worldwide. We ensure regulatory compliance, secure packaging, and timely delivery to hospitals, distributors, pharmacies, and healthcare institutions.
What is Oxaliplatin Injection?
Oxaliplatin 50mg/100mg Injection is an anti-cancer (chemotherapy) medicine widely used in the treatment of:
Colorectal (colon and rectal) cancer
Advanced metastatic colorectal cancer
Combination chemotherapy regimens prescribed by oncologists
Important: This medicine must only be administered under the supervision of qualified healthcare professionals.
Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
✅ Trusted pharmaceutical exporter from India
✅ High-quality oncology product supply
✅ Reliable global distribution network
✅ Competitive export pricing
✅ Secure and temperature-conscious packaging
✅ Fast documentation support
✅ Timely international delivery
✅ Dedicated customer support
Fast Delivery Countries
Cordium Pharmaceuticals Pvt. Ltd. offers fast and reliable export services to:
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇵🇭 Philippines
🇻🇳 Vietnam
🇦🇪 UAE
🇸🇦 Saudi Arabia
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
🇺🇸 USA
🇬🇧 UK
🇿🇦 South Africa
Product Information
Product Name: Oxaliplatin Injection
Strengths Available: 50mg / 100mg
Dosage Form: Injection
Category: Oncology / Anti-Cancer Medicine
Packaging: Export-quality packaging
Origin: India
Manufacturer/Exporter: Cordium Pharmaceuticals Pvt. Ltd.
Global Pharmaceutical Export Partner
Cordium Pharmaceuticals Pvt. Ltd. supports:
Pharmaceutical importers
Hospital procurement departments
Oncology clinics
Government tenders
Pharmaceutical distributors
Wholesalers worldwide
Our efficient logistics network helps ensure smooth export operations and faster deliveries across international markets.